marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2022-Q3
added 11-14-2022
CASI Pharmaceuticals Financial Statements 2011-2024 | CASI
Annual Financial Statements CASI Pharmaceuticals
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.09 B | 371 M | 285 M | 300 M | 255 M | 74.3 M | 35 M | 45.5 M | 49.9 M | 39.6 M | 28.2 M |
Shares |
136 M | 110 M | 95.9 M | 84.8 M | 61.5 M | 55.9 M | 32.4 M | 28.6 M | 26.1 M | 19.1 M | 11.8 M |
Historical Prices |
8.4 | 24.6 | 17.7 | 32.8 | 34.6 | 14.2 | 7.9 | 16.2 | 18.9 | 29.5 | 20.7 |
Net Income |
-36.7 M | -48.3 M | -46 M | -27.5 M | -10.8 M | -9.45 M | -7.21 M | -26.2 M | -5.74 M | -14.5 M | -4.56 M |
Revenue |
30.2 M | 15.1 M | 4.13 M | - | - | - | 47.7 K | 23.7 K | - | 669 K | 1.94 M |
Cost of Revenue |
12.6 M | 9.51 M | 3.94 M | - | - | - | - | - | - | - | - |
Gross Profit |
17.6 M | 5.63 M | 196 K | - | - | - | 41.4 K | 16.3 K | - | 669 K | 1.94 M |
Operating Income |
-41.8 M | -51.5 M | -47 M | -27.2 M | - | - | - | - | - | - | - |
Interest Expense |
2.9 K | 3.1 K | 5.6 K | 7.5 K | 7.5 K | -26.1 K | -81.5 K | -26.6 K | 1.66 K | 10 M | - |
EBITDA |
-41.4 M | -30.1 M | -37.8 M | -24.8 M | -10.6 M | -9.35 M | -7.08 M | -6.46 M | -5.72 M | -4.48 M | -4.53 M |
Operating Expenses |
- | 38.9 M | 40.2 M | 26.5 M | 10.8 M | 9.42 M | 7.19 M | 6.52 M | 5.74 M | 5.17 M | 6.51 M |
General and Administrative Expenses |
23.8 M | 19.7 M | 27.3 M | 18 M | 3.16 M | 4.78 M | 3.12 M | 3.76 M | 2.99 M | 2.8 M | 3.05 M |
All numbers in USD currency
Quarterly Income Statement CASI Pharmaceuticals
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | 13.6 M | 13.6 M | 138 M | 14 M | 14 M | 14 M | 125 M | 124 M | 118 M | 101 K | 98.8 K | 97.8 M | 95.9 K | 95.7 K | 95.6 K | 95.3 M | 81.5 K | 86 M | 71.2 M | 69.8 M | 60.2 M | 60.2 M | 60.2 M | - | 49.2 M | 42.9 M | 40.2 M | - | 32.4 M | 32.4 M | 32.4 M | - | 27.8 M | 27 M | 27 M | 27.1 M | 27 M | 27 M | 23.4 M | 22.6 M | 22.5 M | 19 M | 12.2 M | 12.2 M | 12 M | 11.5 M | 12.2 M |
Net Income |
- | -5.2 M | -7.68 M | -8.6 M | - | -10.2 M | -6.95 M | -13.9 M | - | -17 M | -8.69 M | -8.44 M | - | -9.89 M | -15.5 M | -8.18 M | - | -8.76 M | -5.86 M | -3.59 M | - | -1.61 M | -2.41 M | -1.7 M | - | -1.69 M | -3.29 M | -1.79 M | - | -1.6 M | -2.1 M | -1.8 M | - | -21.5 M | -1.62 M | -1.45 M | - | -1.44 M | -1.85 M | -1.14 M | - | -1.19 M | -10.5 M | -2.53 M | - | -1.31 M | -1.66 M | -2.6 M |
Revenue |
- | 10.2 M | 8.57 M | 9.06 M | - | 8.11 M | 7.16 M | 5.74 M | - | 4.24 M | 2.67 M | 3.41 M | - | 2.79 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 24 K | 23.7 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 8.85 K | - |
Cost of Revenue |
- | 4.25 M | 3.55 M | 3.76 M | - | 3.42 M | 2.98 M | 2.36 M | - | 1.83 M | 2.52 M | 3.21 M | - | 2.65 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | 5.97 M | 5.02 M | 5.3 M | - | 4.7 M | 4.18 M | 3.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | -6.35 M | -7.75 M | -7.29 M | - | -6.89 M | -7.98 M | -15.6 M | - | -18.7 M | -8.89 M | -8.77 M | - | -10.6 M | -15.8 M | -8.32 M | - | -8.71 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | 11 K | 11 K | 38 K | - | 487 K | 33 K | 1 M | - | 1.2 K | 700 | 190 K | - | 414 K | 320 K | 49 K | - | 11 K | 13.1 K | 6.73 K | - | -546 | -72 | 142 | - | -5.61 K | -8.76 K | -8.77 K | - | -24.3 K | -24.3 K | -24.2 K | - | -2.93 K | 129 | 384 | - | 408 | 443 | -390 | - | - | 9.17 M | 876 K | - | - | - | - |
EBITDA |
- | -5.79 M | -7.64 M | -7.2 M | - | -6.5 M | -7.67 M | -15.4 M | - | -18.3 M | -8.61 M | -8.62 M | - | -10.1 M | -15.2 M | -8.19 M | - | -8.46 M | 142 K | 65.8 K | - | 69.4 K | 37.9 K | 18.5 K | - | 48 K | 32.5 K | 19 K | - | 50.8 K | 33.2 K | 16.5 K | - | 32.7 K | 19.2 K | 6.53 K | - | 12.9 K | 9.04 K | 4.66 K | - | 15.1 K | 9.38 K | 4.23 K | - | 33.6 K | 23.7 K | 12.1 K |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | 4.85 M | 5.52 M | 5.32 M | - | 5.26 M | 5.49 M | 5.5 M | - | 5.35 M | 4.08 M | 4.06 M | - | 7.98 M | 6.98 M | 5.71 M | - | 6.9 M | 4.04 M | 1.3 M | - | 626 K | 691 K | 644 K | - | 677 K | 1.91 M | 765 K | - | 674 K | 858 K | 925 K | - | 1.15 M | 892 K | 891 K | - | 663 K | 1.02 M | 630 K | - | 565 K | 602 K | 1.1 M | - | 557 K | 720 K | 1.25 M |
All numbers in USD currency